Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis
Top Cited Papers
- 1 August 2006
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 368 (9536), 679-686
- https://doi.org/10.1016/s0140-6736(06)69252-0
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The World Health report 2006 1 : Working together for health 2Published by Taylor & Francis ,2006
- Cost-Effectiveness Analysis of Hypertension Guidelines in South AfricaCirculation, 2005
- Folate supplementation and cardiovascular diseaseThe Lancet, 2005
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyThe Lancet, 2004
- Efficacy of substituting innovator propafenone for its generic formulation in patients with atrial fibrillationThe American Journal of Cardiology, 2004
- Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysisBMJ, 2003
- Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease riskThe Lancet, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990
- The Decision Concerning Coronary Angiography in Patients with Chest PainMedical Decision Making, 1985